-
EP1259469
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1259469
| EP1259469 - METHODS OF STRUCTURE-BASED DRUG DESIGN USING MS/NMR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.05.2004 Database last updated on 12.07.2024 | Most recent event Tooltip | 21.05.2004 | Application deemed to be withdrawn | published on 07.07.2004 [2004/28] | Applicant(s) | For all designated states Wyeth Five Giralda Farms Madison, NJ 07940-0874 / US | [N/P] |
| Former [2002/48] | For all designated states Wyeth Five Giralda Farms Madison, New Jersey 07940-0874 / US | Inventor(s) | 01 /
POWERS, Robert 3 Magnolia Drive Westford, MA 01886 / US | 02 /
MOY, Franklin, Joseph 37 Burch Street Arlington, MA 02474 / US | 03 /
SIEGEL, Marshall, Mayer 39-24 Grant Street Fair Lawn, NJ 07410 / US | 04 /
MOBILIO, Dominick 35 Sneider Road Warren, NJ 07059 / US | [2002/48] | Representative(s) | Wileman, David Francis Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead Berkshire SL6 OPH / GB | [N/P] |
| Former [2002/48] | Wileman, David Francis Dr. Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead, Berkshire SL6 OPH / GB | Application number, filing date | 01911041.0 | 21.02.2001 | [2002/48] | WO2001US05495 | Priority number, date | US20000513806 | 25.02.2000 Original published format: US 513806 | [2002/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0162688 | Date: | 30.08.2001 | Language: | EN | [2001/35] | Type: | A2 Application without search report | No.: | EP1259469 | Date: | 27.11.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.08.2001 takes the place of the publication of the European patent application. | [2002/48] | Search report(s) | International search report - published on: | EP | 14.03.2002 | Classification | IPC: | C07B61/00 | [2002/48] | CPC: |
G01N33/53 (EP);
G01N33/538 (EP);
G01N33/542 (EP);
G01N33/6803 (EP);
G01N2333/8146 (EP);
G01N2333/96486 (EP);
G01N2500/20 (EP)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/48] | Extension states | AL | 08.08.2002 | LT | 08.08.2002 | LV | 08.08.2002 | MK | Not yet paid | RO | 08.08.2002 | SI | 08.08.2002 | Title | German: | VERFAHREN ZUM AUF DER STRUKTUR BASIERENDEN ENTWURF VON ARZNEIMITTELN MIT HILFE DER NMR/MS | [2002/48] | English: | METHODS OF STRUCTURE-BASED DRUG DESIGN USING MS/NMR | [2002/48] | French: | PROCEDE DE CONCEPTION DE MEDICAMENTS FONDES SUR LA STRUCTURE UTILISANT LA SPECTROMETRIE DE MASSE ET LA RESONANCE MAGNETIQUE NUCLEAIRE | [2002/48] | Entry into regional phase | 08.08.2002 | National basic fee paid | 08.08.2002 | Designation fee(s) paid | 08.08.2002 | Examination fee paid | Examination procedure | 20.08.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 08.08.2002 | Examination requested [2002/48] | 16.06.2003 | Despatch of a communication from the examining division (Time limit: M06) | 30.12.2003 | Application deemed to be withdrawn, date of legal effect [2004/28] | 04.02.2004 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/28] | Fees paid | Renewal fee | 06.02.2003 | Renewal fee patent year 03 | 04.02.2004 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US5891742 (DOLLINGER GAVIN D ET AL) [Y] 1-25 * column 1, line 60 - column 2, line 2; claims 1-4 *; | [Y]WO9718469 (ABBOTT LAB) [Y] 1-25 * page 6, line 22 - page 8, line 9; claims 1-18 *; | [Y]EP0981049 (ABBOTT LAB) [Y] 1-25 * page 4, line 55 - page 5, line 57; claims 1-7 *; | [A]WO9737953 (GLAXO GROUP LTD ;KINDER DANIEL START (US); WAGNER CRAIG DANIEL (US) [A] 1-25 * page 10, lines 20-32; claims 1,3,12 *; | [PA]WO0047999 (DUNAYEVSKIY YURIY M ;CETEK CORP (US); HUGHES DALLAS E (US)) [PA] 1-25 * figure 1; claim 1 *; | [DA] - S B SHUKER ET AL, "Discovering High-Affinity Ligands for Proteins: SAR by NMR", SCIENCE,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,,US, (1996), no. 274, ISSN 0036-8075, pages 1531 - 1534, XP002074440 [DA] 1-25 * the whole document * DOI: http://dx.doi.org/10.1126/science.274.5292.1531 | [PX] - MOY F J ET AL, "MS/NMR: a structure-based approach for discovering protein ligands and for drug design by coupling size exclusion chromatography, mass spectrometry, and nuclear magnetic resonance spectroscopy.", ANALYTICAL CHEMISTRY, (2001 FEB 1) 73 (3) 571-81., XP002173753 [PX] 1-25 * the whole document * DOI: http://dx.doi.org/10.1021/ac0006270 | [PA] - DEAR G J ET AL, "Mass directed peak selection, an efficient method of drug metabolite identification using directly coupled liquid chromatography-mass spectrometry-nuclear magnetic resonance spectroscopy", JOURNAL OF CHROMATOGRAPHY. BIOMEDICAL APPLICATIONS,ELSEVIER, AMSTERDAM,NL, (20001001), vol. 748, no. 1, ISSN 0378-4347, pages 281 - 293, XP004224403 [PA] 1-25 * the whole document * DOI: http://dx.doi.org/10.1016/S0378-4347(00)00291-7 |